Prolactinoma laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Prolactinoma}}
{{Prolactinoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}} {{AE}},{{Anmol}}, {{Faizan}}


==Overview==
==Overview==
Laboratory findings consistent with the diagnosis of prolactinoma include markedly elevated [[prolactin]] levels and reduced [[thyroid]] hormone levels.
Laboratory findings consistent with the diagnosis of prolactinoma include markedly elevated [[prolactin]] levels.


==Laboratory Findings==
==Laboratory Findings==
Laboratory findings consistent with the [[diagnosis]] of prolactinoma include:
*Prolactin levels - Serum prolactin concentration may be markedly higher than normal (usually >200ng/ml).
:*[[Blood]] [[prolactin]] concentration may be markedly higher than normal (usually >250 ng/ml)
*TSH levels - Thyrotropin releasing hormone(TRH) also stimulated prolactin secretion. Thyroid stimulating hormone(TSH) is measured. If TSH is elevated, free thyroxine (T4) level must be done to confirm that TSH elevation is due to elevated TRH and  not due to decreased T4(hypothyroidism).
:*Reduced blood concentration of [[testosterone]] in men
*Pregnancy test: Urine pregnancy test(beta-hcg) is performed as pregnancy causes physiologic rise is prolactin levels.
:*Decreased blood concentration of [[thyroid]] hormones
*Serum testosterone levels: Low levels are found in male presenting with symptoms of hypogonadism.
*IGF-1: Insulin-like growth factor levels may be done in patients with findings suggestive of acromegaly.
*Cortisol levels: Cortisol levels may be done in patients with finding suggestive of Cushing's syndrome.
*LFT: Liver function tests may be done in patients with appropriate history to exclude cirrhosis or viral hepatitis as cause of elevated prolactin.
*RFT: Renal function tests may be done in patients with appropriate history to exclude chronic renal failure as cause of elevated prolactin.
 
 
====Hook effect====
*Hook effect is a phenomenon which occurs particularly in macroprolactinoma.<ref name="pmid8729527">{{cite journal| author=St-Jean E, Blain F, Comtois R| title=High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. | journal=Clin Endocrinol (Oxf) | year= 1996 | volume= 44 | issue= 3 | pages= 305-9 | pmid=8729527 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8729527  }} </ref>
*In patients with macroprolactinoma, the reading of initial prolactin level may be mistakenly normal or mildly increased.
*These false values are due large amount of antigens. So, this is also called as 'high dose hook effect'.
*All patients of pituitary macroadenomas shall underogo immunoradiometric prolactin assay with multiple dilution if prolactinoma is suspected.


== References ==
== References ==

Revision as of 17:20, 21 July 2017

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma laboratory tests

CDC on Prolactinoma laboratory tests

Prolactinoma laboratory tests in the news

Blogs on Prolactinoma laboratory tests

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: , Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]

Overview

Laboratory findings consistent with the diagnosis of prolactinoma include markedly elevated prolactin levels.

Laboratory Findings

  • Prolactin levels - Serum prolactin concentration may be markedly higher than normal (usually >200ng/ml).
  • TSH levels - Thyrotropin releasing hormone(TRH) also stimulated prolactin secretion. Thyroid stimulating hormone(TSH) is measured. If TSH is elevated, free thyroxine (T4) level must be done to confirm that TSH elevation is due to elevated TRH and not due to decreased T4(hypothyroidism).
  • Pregnancy test: Urine pregnancy test(beta-hcg) is performed as pregnancy causes physiologic rise is prolactin levels.
  • Serum testosterone levels: Low levels are found in male presenting with symptoms of hypogonadism.
  • IGF-1: Insulin-like growth factor levels may be done in patients with findings suggestive of acromegaly.
  • Cortisol levels: Cortisol levels may be done in patients with finding suggestive of Cushing's syndrome.
  • LFT: Liver function tests may be done in patients with appropriate history to exclude cirrhosis or viral hepatitis as cause of elevated prolactin.
  • RFT: Renal function tests may be done in patients with appropriate history to exclude chronic renal failure as cause of elevated prolactin.


Hook effect

  • Hook effect is a phenomenon which occurs particularly in macroprolactinoma.[1]
  • In patients with macroprolactinoma, the reading of initial prolactin level may be mistakenly normal or mildly increased.
  • These false values are due large amount of antigens. So, this is also called as 'high dose hook effect'.
  • All patients of pituitary macroadenomas shall underogo immunoradiometric prolactin assay with multiple dilution if prolactinoma is suspected.


References

  1. St-Jean E, Blain F, Comtois R (1996). "High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas". Clin Endocrinol (Oxf). 44 (3): 305–9. PMID 8729527.


Template:WikiDoc Sources